Company

About

ANT Neuro

ANT Neuro

Welbergweg 74, Hengelo, Overijssel 7556, NL

ANT Neuro is a Dutch corporation specialized in the development, marketing and sales of medical and research applications. ANT Neuro was established in 1997 as a spin-off company of The University of Twente, Enschede. It now has offices located in Hengelo, Netherlands; Berlin, Germany; London, UK; Philadelphia, USA; Melbourne, Australia; and Hong Kong, China. ANT Neuro specializes in being a single-source provider of high performance products within neuroscience research and neurodiagnostics. Applications include EEG, EMG, TMS and MEG technology.

Avantium

Avantium

Amsterdam, Netherlands

Avantium develops and commercialises innovative chemistry technologies in order to produce chemicals and materials based on renewable feedstock instead of fossil resources. Our two lead products are FDCA and plantMEG™. Together, they enable the production of the novel plastic PEF: 100% plant-based, recyclable and degradable with superior performance. Avantium also provides advanced catalysis products and services to organisations who desire to gain efficiency in their processes.

Future Genomics Technologies

Future Genomics Technologies

Sylviusweg 74, Leiden, Zuid-Holland 2333 BE, NL

New DNA technologies are rapidly being developed and will have an increasing impact on the world and on people's daily life. Future Genomics Technologies aims to translate academic knowledge and novel technologies into usable applications and provide early and easy access to these applications. Our mission is to help you achieve your goals using cutting edge sequencing and bioinformatics technology.

Hycult Biotech

Hycult Biotech

2a frontstraat, uden, noord-brabant, netherlands

Hycult Biotech is a Netherlands-based biotechnology company that specializes in research reagents and tools for complement system analysis and innate immunity research. Established in 1994, the company has over 30 years of experience in developing monoclonal antibodies, ELISA kits, and proteins aimed at advancing diagnostics and therapeutic research. Hycult serves as a trusted partner for academic, pharmaceutical, and biotech researchers, providing products to study immune-related diseases. The company emphasizes collaborative innovation, working closely with scientists worldwide to tackle challenges in disease monitoring and treatment. In 2019, Hycult enhanced its capabilities by acquiring Biocult, a specialist in monoclonal antibody production, which bolstered its contract manufacturing services. The company offers a range of products, including ELISA kits, monoclonal antibodies, and proteins, along with large-scale antibody production and support tools for data analysis.

LUMICKS

LUMICKS

Pilotenstraat 41, Amsterdam, North Holland 1059 CH, NL

LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.

NecstGen

NecstGen

Sylviusweg 62, Leiden, South Holland 2333 BE, NL

The Netherlands Center for the Clinical advancement of Cell and Gene Therapies (NecstGen), situated in Leiden, comprises of a state-of-the-art facility and expert knowledge for the development, production, and commercialization of Cell and Gene Therapies. NecstGen helps academic and industrial Cell & Gene Therapy developers to enter the clinical stage by bringing together the required expertise from R&D, development, production, QA, QC and regulatory affairs in a brand new 4,000 m2 development & GMP manufacturing facility. We enable the next generation of therapies by translating research programs into actionalbe health solutions for patients. Our service offering: A flexible Cell and Gene Therapy manufacturing model - Full contract manufacturing services by our expert team for Cell Therapy and Viral Vector - We manufacture Pre-clinical or toxicology study material, Phase I, Phase II clinical trial material - GMP rental for any mammalian cell-based therapy type, including Cell and Viral Vector based therapies - QC, QA, and QP services supporting our cleanroom rental - Hybrid support on a flexible basis where our team compliments yours Process and assay development for Cell Therapies and Viral Vector - Process design and optimisation - Scale-up to clinically relevant volumes - Automation and closed processes - Assay development for in-process controls, release- and potency tests - Technology transfer in and out with flexibility in-mind for the future progress of your manufacturing - Consultancy-based work to advise on decision making Talk to NecstGen today about your needs for: - Induced Pluripotent Stem Cells (iPSC) - Chimeric Antigen Receptor T-Cells (CAR-T), Tumor Infiltrating Lymphocytes (TIL) T-Cell Receptor Modified T-Cells (TCR-T) - Natural Killer (NK) Cells/CAR-NK Cells - Dendritic Cells (DC) - Mesenchymal Stromal Cells (MSC) - Lentivirus (LV) - Aden-associated virus (AAV) - Oncolytic viruses - Cleanroom rental for any mammalian cell-based therapy type